Sionna Therapeutics Statistics
Total Valuation
SION has a market cap or net worth of $134.35 million. The enterprise value is -$107.70 million.
Important Dates
The last earnings date was Tuesday, November 10, 2026, before market open.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SION has 45.24 million shares outstanding. The number of shares has increased by 50.15% in one year.
| Current Share Class | 45.24M |
| Shares Outstanding | 45.24M |
| Shares Change (YoY) | +50.15% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 1.43% |
| Owned by Institutions (%) | 53.33% |
| Float | 20.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.92, with a Debt / Equity ratio of 0.03.
| Current Ratio | 13.92 |
| Quick Ratio | 13.68 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.96% and return on invested capital (ROIC) is -24.68%.
| Return on Equity (ROE) | -38.96% |
| Return on Assets (ROA) | -23.71% |
| Return on Invested Capital (ROIC) | -24.68% |
| Return on Capital Employed (ROCE) | -46.31% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.86M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.41% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -92.41% |
| 50-Day Moving Average | 4.57 |
| 200-Day Moving Average | 27.42 |
| Relative Strength Index (RSI) | 27.62 |
| Average Volume (20 Days) | 729,972 |
Short Selling Information
The latest short interest is 4.21 million, so 9.31% of the outstanding shares have been sold short.
| Short Interest | 4.21M |
| Short Previous Month | 3.68M |
| Short % of Shares Out | 9.31% |
| Short % of Float | 20.55% |
| Short Ratio (days to cover) | 4.11 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -114.30M |
| Pretax Income | -109.52M |
| Net Income | -109.52M |
| EBITDA | -113.69M |
| EBIT | -114.30M |
| Earnings Per Share (EPS) | -$2.43 |
Full Income Statement Balance Sheet
The company has $249.80 million in cash and investments and $7.75 million in debt, with a net cash position of $242.05 million or $5.35 per share.
| Cash & Investments | 249.80M |
| Total Debt | 7.75M |
| Net Cash | 242.05M |
| Net Cash Per Share | $5.35 |
| Equity (Book Value) | 240.52M |
| Book Value Per Share | 5.32 |
| Working Capital | 212.11M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$79.41 million and capital expenditures -$204,000, giving a free cash flow of -$79.61 million.
| Operating Cash Flow | -79.41M |
| Capital Expenditures | -204,000 |
| Depreciation & Amortization | 615,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -79.61M |
| FCF Per Share | -$1.76 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SION does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -50.15% |
| Shareholder Yield | -50.15% |
| Earnings Yield | -81.96% |
| FCF Yield | -59.26% |
Analyst Forecast
The average price target for SION is $21.00, which is 607.07% higher than the current price. The consensus rating is "Hold".
| Price Target | $21.00 |
| Price Target Difference | 607.07% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |